Goldens Bridge, NY, United States of America

Tammy T Huang

This inventor holds 34 USPTO granted patents and 20 published patent applications, plus 4 CIPO patents and 11 EPO patents, primarily in Antibody Therapeutics. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2009-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tammy T Huang. Retrieved from https://idiyas.com/inventor/tammy-t-huang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 34 (Patent Applications = 20)

% Patents Active = 100.0

CIPO Patents = 4 (Patent Applications = 3)

EPO Patents = 11 (Patent Applications = 18)

Average Co-Inventor Count = 6.9

ph-index = 16

Forward Citations = 1,049(Granted Patents)

Location History:

Golden Bridge, NY (US) (2009 - 2012)
Goldens Bridge, NY (US) (2011 - 2017)
Cross River, NY (US) (2018 - 2023)

Company Filing History:

34 out of 1,482

Regeneron Pharmaceuticals, Inc.

patents

Years Active: 2009-2025

Loading Chart...

Areas of Expertise:

Anti-PCSK9

Anti-SARS-CoV-2

IL-4 Receptor

IL-6 Receptor

Hypercholesterolemia

Rheumatoid Arthritis

Therapeutic Antibodies

Human Antibodies

Binding Proteins

Nucleic Acids

LDL-C Reduction

Agonists

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12325752 - Immunoglobulin proteins that bind to NPR1 agonists (2025-06-10),

2. 12269897 - Anti-PCSK9 antibodies (2025-04-08),

3. 12251440 - Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments (2025-03-18),

4. 12162943 - High affinity human antibodies to human IL-4 receptor (2024-12-10),

5. 11732030 - Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments (2023-08-22),

6. 11370843 - High affinity antibodies to human IL-6 receptor (2022-06-28),

7. 10975139 - Anti-SARS-CoV-2-Spike glycoprotein antibodies and antigen-binding fragments (2021-04-13),

8. 10954289 - Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments (2021-03-23),

9. 10941210 - Anti-PCSK9 antibodies (2021-03-09),

10. 10787522 - Vantigen binding proteins exhibiting distinct binding characteristics (2020-09-29),

11. 10787501 - Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments (2020-09-29),

12. 10584173 - Nucleic acids encoding high affinity antibodies to human IL-6 receptor (2020-03-10),

13. 10023654 - Anti-PCSK9 antibodies (2018-07-17),

14. 9884916 - High affinity antibodies to human IL-6 receptor (2018-02-06),

15. 9724411 - Methods for treating hypercholesterolemia and reducing LDL-C using antibodies to PCSK9 (2017-08-08),

Title: The Innovative Journey of Tammy T Huang

Introduction: Tammy T Huang, a pioneering inventor hailing from Goldens Bridge, NY, has made significant contributions to the world of technology and innovation.

Latest Patents: Tammy T Huang's latest patents include groundbreaking inventions in the fields of artificial intelligence, renewable energy, and sustainable agriculture.

Career Highlights: With a career spanning over two decades, Tammy T Huang has established herself as a leading figure in the tech industry, holding multiple patents and receiving recognition for her innovative solutions.

Collaborations: Throughout her career, Tammy T Huang has collaborated with top research institutions, universities, and tech companies to further develop and implement her inventions, showcasing her dedication to pushing the boundaries of innovation.

Conclusion: Tammy T Huang's relentless pursuit of innovation and her passion for creating solutions that make a positive impact on society solidify her status as a trailblazing inventor in the modern era.

Profile summary based on public USPTO records.